Panacea Biotec Ltd

BSE: 531349

18

total announcements

PANACEABIO.NS · 15 min delayed

Key Stats · Yahoo Finance · as of 24 Oct 2026

Market Cap

₹1,903 Cr

EPS (TTM)

₹-1.16

52W Low

₹292.40

52W High

₹647.00

Dividend Yield

0.00%

Beta

0.25

Price / Book

2.4

Debt / Equity

2.9

Revenue (TTM)

₹673 Cr

Gross Margin

54.66%

Operating Margin

-1.12%

AnnouncementsDiscussion
BSECompany Update9 Oct 2026

Panacea Biotec Ltd

Please find attached newspaper copies regarding notice intimating the investors about the opening of special window for transfer and dematerialisation of physical shares

Panacea Biotec Ltd has announced the opening of a special window for transfer and dematerialization of physical shares, in accordance with SEBI Circular No. HO/38/13/11(2)2026-MIRSD-POD/I/3750/2026, published on October 9, 2026, in the Financial Express and Desh Sewak (Punjabi) newspapers.

Read more →📎 1 attachment
BSECompany Update7 Oct 2026

Panacea Biotec Ltd

Please find attached certificate dated October 01, 2026 issued by Skyline Financial Services Pvt. Ltd. ("RTA") confirming compliance under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.

Panacea Biotec Ltd has issued a compliance certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, confirming the dematerialization of securities for the quarter ended September 30, 2026.

Read more →📎 1 attachment
BSEAGM/EGM29 Sept 2026

Panacea Biotec Ltd

Please find attached proceedings of the 42nd Annual General meeting of the Company held on Tuesday, September 29, 2026 at 11:30 A.M. through Video Conferencing.

Panacea Biotec Ltd held its 42nd Annual General Meeting on September 29, 2026, through video conferencing. The meeting was attended by several directors and officials, and the proceedings were deemed to be conducted at the company's registered office. The company provided remote e-voting facility to its members, and the voting results will be submitted in due course of time.

Read more →📎 1 attachment
BSECompany Update▼ NegativeRegulatory29 Sept 2026

Panacea Biotec Ltd

We would like to inform you that the Company has received 2 Demand Orders dated 28.09.2026, from the Office of the Assistant Commissioner of Income Tax, Delhi imposing penalty on account of alleged misreporting / under reporting of income , resulting into demand aggregating to ~Rs.4.32 Crore. The requisite details are enclosed herewith.

Panacea Biotec Ltd has received two Demand Orders from the Office of the Assistant Commissioner of Income Tax, Delhi, imposing a penalty of ~₹4.32 Crore on account of alleged misreporting/under reporting of income for Assessment Years 2022-23 and 2023-24.

Read more →📎 1 attachment
BSECompany Update▼ NegativeRegulatory26 Sept 2026

Panacea Biotec Ltd

The Company has received four Demand Orders from the Office of the Assistant Commissioner of Income Tax, Delhi under Section 156 of the Income Tax Act, 1961 ("Act") imposing penalty on account of alleged misreporting / under reporting of income, resulting into demand aggregating to ~Rs.9.82 Crore. The requisite details as required under SEBI LODR Regulations read with Industry Standards are enclosed herewith.

Panacea Biotec Ltd has received four Demand Orders from the Office of the Assistant Commissioner of Income Tax, Delhi, imposing a penalty of ~₹9.82 Crore on account of alleged misreporting/under reporting of income.

Read more →📎 1 attachment
BSEInsider Trading / SAST26 Sept 2026

Panacea Biotec Ltd

The trading window of the Company shall remain closed for all the Designated Persons (including their immediate relatives) of the Company from October 01, 2026 till completion of 48 hours from the announcement of the unaudited financial results of the Company for the quarter and half year ending September 30, 2026, to the Stock Exchanges. The date of meeting of the Board of Directors to approve the unaudited financial results of the Company for ....

Panacea Biotec Ltd has announced the closure of its trading window for designated persons from October 1, 2026, until 48 hours after the announcement of unaudited financial results for the quarter and half year ending September 30, 2026.

Read more →📎 1 attachment
BSECompany UpdateRegulatory24 Jul 2026

Panacea Biotec Ltd

The Company''s wholly owned subsidiary, Panacea Biotec Pharma Ltd. has received a Show Cause Notice (SCN) dated July 23, 2026, from the office of the Assistant Commissioner, Goods and Services ....

Panacea Biotec Ltd's wholly owned subsidiary, Panacea Biotec Pharma Ltd, has received a Show Cause Notice from the Assistant Commissioner, Goods and Services Tax, Delhi, alleging a tax liability of ₹4.06 Crore, including interest and penalty, on account of excess claim of Input Tax Credit in the Annual Return filed for the Financial Year 2022-23.

Read more →📎 1 attachment